NCT01014546View on ClinicalTrials.gov

Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis

PHASE1TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Essential ThrombocythemiaPolycythemia VeraPrimary Myelofibrosis
Interventions
DRUG

Arsenic Trioxide

Given PO

DIETARY_SUPPLEMENT

Ascorbic Acid

Given PO

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Pharmacological Study

Correlative studies

Trial Locations (1)

14263

Roswell Park Cancer Institute, Buffalo

Sponsors

Collaborators (1)

Cephalon, Inc.
All Listed Sponsors
collaborator

Cephalon, Inc.

INDUSTRY

lead

Roswell Park Cancer Institute

OTHER